Cargando…

Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients

Scarce data exist on concurrent chemotherapy in locally advanced cervical cancer (LACC) patients (pts) treated with image-guided adaptive brachytherapy (IGABT). We examined the effect of a number of chemotherapy cycles and their interaction with brachytherapy dose/volume parameters. Clinical records...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escande, Alexandre, Khettab, Mohamed, Bockel, Sophie, Dumas, Isabelle, Schernberg, Antoine, Gouy, Sebastien, Morice, Philippe, Pautier, Patricia, Deutsch, Eric, Haie-Meder, Christine, Chargari, Cyrus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356737/ https://www.ncbi.nlm.nih.gov/pubmed/32492777 http://dx.doi.org/10.3390/jcm9061653

Ejemplares similares

Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy
por: Bockel, Sophie, et al.
Publicado: (2019)

Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy?
por: Escande, Alexandre, et al.
Publicado: (2016)

Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review
por: Bockel, Sophie, et al.
Publicado: (2021)

Brachytherapy for the Conservative Treatment of Female Peri-Urethral Carcinoma
por: Andraud, Mickaël, et al.
Publicado: (2022)

Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy
por: Holub, Katarzyna, et al.
Publicado: (2020)

Pulsed Dose Rate Brachytherapy of Lip Carcinoma: Clinical Outcome and Quality of Life Analysis
por: El Ayachy, Radouane, et al.
Publicado: (2021)

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
por: Seban, Romain-David, et al.
Publicado: (2019)

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation
por: Kumar, T, et al.
Publicado: (2019)

Prediction of cervical cancer recurrence using textural features extracted from (18)F-FDG PET images acquired with different scanners
por: Reuzé, Sylvain, et al.
Publicado: (2017)

Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients’ health quality perception
por: Bourdais, Rémi, et al.
Publicado: (2021)

Implementation of Image-Guided Brachytherapy for Pediatric Vaginal Cancers: Feasibility and Early Clinical Results
por: Terlizzi, Mario, et al.
Publicado: (2022)

Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France
por: Bentahila, Rita, et al.
Publicado: (2022)

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae
por: Sun, Roger, et al.
Publicado: (2018)

Cervical Cancer and Fertility-Sparing Treatment
por: Zaccarini, François, et al.
Publicado: (2021)

Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies
por: Zhou, Yuedan, et al.
Publicado: (2022)

Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2017)

False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology
por: Gouy, Sebastien, et al.
Publicado: (2021)

Brachytherapy Issues and Priorities in the Context of the Coronavirus Disease 2019 (COVID-19) Outbreak
por: Chargari, Cyrus, et al.
Publicado: (2020)

Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients
por: Deutsch, Eric, et al.
Publicado: (2016)

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy
por: Schernberg, Antoine, et al.
Publicado: (2018)

Venezia applicator with oblique needles improves clinical target volume coverage in distal parametrial tumor residue compared to parallel needles only
por: Kissel, Manon, et al.
Publicado: (2021)

Thromboembolic events following brachytherapy: case reports
por: Guy, Jean-Baptiste, et al.
Publicado: (2015)

Optimization of Patient Management During the COVID-19 Pandemic: Chest CT Scan and PCR as Gatekeepers of the Radiation Therapy Workflow
por: Sun, Roger, et al.
Publicado: (2020)

Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2018)

Metabolic features of cancer cells impact immunosurveillance
por: Joseph, Adrien, et al.
Publicado: (2021)

Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?
por: Sun, Roger, et al.
Publicado: (2022)

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer
por: Schernberg, Antoine, et al.
Publicado: (2018)

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
por: Gouy, Sebastien, et al.
Publicado: (2017)

Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types
por: Gouy, Sebastien, et al.
Publicado: (2017)

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
por: Leary, Alexandra, et al.
Publicado: (2020)

Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis
por: Annede, Pierre, et al.
Publicado: (2023)

Correlation Between Serum and Urine Biomarkers and the Intensity of Acute Radiation Cystitis in Patients Treated With Radiation Therapy for Localized Prostate Cancer: Protocol for the Radiotoxicity Bladder Biomarkers (RABBIO) Study
por: Helissey, Carole, et al.
Publicado: (2023)

Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members
por: Kissel, Manon, et al.
Publicado: (2022)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2020)

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy
por: Dimopoulos, Johannes C.A., et al.
Publicado: (2012)

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019)

Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot
por: Sun, Roger, et al.
Publicado: (2021)

Image-Guided Adaptive Brachytherapy (IGABT) for Primary Vaginal Cancer: Results of the International Multicenter RetroEMBRAVE Cohort Study
por: Westerveld, Henrike, et al.
Publicado: (2021)

Dépistage systématique de l’épidémie à coronavirus 2019 en radiothérapie par scanographie thoracique et PCR : expérience d’un centre
por: Sun, R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_brcj0rirata0k8ala742ab7u6t